Case number 1:17-cv-01201
Teva Pharmaceuticals International GmbH et al v. Fresenius Kabi USA, LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 6, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per Final Judgment Order in Lead Case. CA. NO. 17-1154-CFC. (fms) |
| Sep 25, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Helen H. Ji for Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Sep 25, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:17-cv-01154-CFC, 1:17-cv-01164-CFC, 1:17-cv-01201-CFC, 1:17-cv-01790-CFC, 1:18-cv-00117-CFC (rjb) |
| Aug 9, 2018 | 26 | Redacted Document (5) Docket Text: REDACTED VERSION of [24] Proposed Consent Judgment by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Aug 9, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [24] Proposed Consent Judgment and Stipulation of Dismissal filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 8/8/18. (ntl) |
| Aug 2, 2018 | 25 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Karen E. Keller regarding Proposed Consent Judgment and Stipulation of Dismissal - re (24 in 1:17-cv-01201-LPS) Proposed Consent Judgment. (Keller, Karen) |
| Jul 25, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:17-cv-01154-LPS, 1:17-cv-01164-LPS, 1:17-cv-01201-LPS, 1:17-cv-01790-LPS, 1:18-cv-00117-LPS (rjb) |
| Dec 13, 2017 | N/A | Remark (0) Docket Text: Remark - These cases have been consolidated for ALL PURPOSED. All future filings shall be made ONLY in Lead C.A. No. 17-1154-GMS. Associated Cases: 1:17-cv-01154-GMS, 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(mdb) |
| Dec 13, 2017 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Gregory M. Sleet - Scheduling Conference held on 12/13/2017. Discussion about the competing schedule proposals between the parties. After counsel conferred outside of court's presence, the court assigns the following dates: A Markman Hearing (full day) is set for 9/4/2018 at 9:30 AM in Courtroom 4A, the Final Proposed Pretrial Order is due by the close of business on 7/29/2019, the Final Pretrial Conference is set for 8/19/2019 at 10:00 AM in Courtroom 4A, and a 10-day Bench Trial is set for 9/3/2019 at 9:00 AM in Courtroom 4A. These cases are consolidated for all purposes; all future filings are to be made ONLY in Lead C.A. No. 17-1154-GMS. These cases will not be referred to the Magistrate Judge for exploring ADR. The plaintiffs shall file an amended scheduling order within seven (7) days of today. (Court Reporter Kevin Maurer.) Associated Cases: 1:17-cv-01154-GMS, 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(mdb) |
| Dec 8, 2017 | 23 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Fresenius Kabi USA, LLC's First Set of Requests for the Production of Documents and Things to Plaintiffs Teva Pharmaceuticals International GmbH, Cephalon, Inc., and Eagle Pharmaceuticals, Inc. filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Dec 7, 2017 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Identification of Asserted Patents and Accused Products filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Dec 1, 2017 | N/A | Oral Order (0) Docket Text: ORAL ORDER re (20 in 1:17-cv-01201-GMS, 18 in 1:17-cv-01154-GMS, 15 in 1:17-cv-01164-GMS) Joint Status Report - A Scheduling Conference is set for Wednesday, December 13, 2017 at 10:00 AM (EST)in Courtroom 4A. Ordered by Judge Gregory M. Sleet on 12/1/2017. Associated Cases: 1:17-cv-01154-GMS, 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(mdb) |
| Nov 7, 2017 | 21 | Proposed Order (13) Docket Text: PROPOSED ORDER [Scheduling Order] by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Nov 7, 2017 | 20 | Status Report (13) Docket Text: Joint STATUS REPORT by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Nov 2, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [19] STIPULATION TO EXTEND TIME to submit a Proposed Schedule and Joint Status Report to November 7, 2017 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc.. Ordered by Judge Gregory M. Sleet on 11/2/2017. (mdb) |
| Oct 30, 2017 | 19 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a Proposed Schedule and Joint Status Report to November 7, 2017 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Oct 20, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [18] STIPULATION TO EXTEND TIME to Submit a Proposed Schedule and Joint Status Report to October 30, 2017 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc.. Ordered by Judge Gregory M. Sleet on 10/20/2017. (mdb) |
| Oct 18, 2017 | 18 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Schedule and Joint Status Report to October 30, 2017 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Oct 18, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kenneth G. Schuler for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Oct 16, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin M. Nelson for Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Oct 13, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [16] MOTION for Pro Hac Vice Appearance of Attorney Kevin M. Nelson and Helen H. Ji filed by Fresenius Kabi USA, LLC, [17] MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler filed by Eagle Pharmaceuticals, Inc.. Ordered by Judge Gregory M. Sleet on 10/13/2017. (mdb) |
| Oct 12, 2017 | 17 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler - filed by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Oct 12, 2017 | 16 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kevin M. Nelson and Helen H. Ji - filed by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Oct 12, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Daniel G. Brown, Michelle L. Ernst, Marc N. Zubick for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Oct 12, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (15 in 1:17-cv-01201-GMS, 14 in 1:17-cv-01154-GMS, 12 in 1:17-cv-01164-GMS) MOTION for Pro Hac Vice Appearance of Attorney Marc N. Zubick, Daniel G. Brown, and Michelle L. Ernst filed by Eagle Pharmaceuticals, Inc.. Ordered by Judge Gregory M. Sleet on 10/12/2017. Associated Cases: 1:17-cv-01164-GMS, 1:17-cv-01154-GMS, 1:17-cv-01201-GMS(mdb) |
| Oct 11, 2017 | 15 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Marc N. Zubick, Daniel G. Brown, and Michelle L. Ernst - filed by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Oct 6, 2017 | 14 | Answer to Counterclaim (15) Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Shaw, John) |
| Sep 18, 2017 | 13 | Notice (Other) (1) Docket Text: NOTICE of Appearance of Arun J. Mohan by Fresenius Kabi USA, LLC (Farnan, Brian) |
| Sep 18, 2017 | 12 | Order (2) Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 9/18/2017. (asw) |
| Sep 15, 2017 | 10 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint,, , COUNTERCLAIM against All Plaintiffs by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 15, 2017 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Fresenius Kabi USA, Inc., Other Affiliate Fresenius Kabi Pharmaceuticals Holding, Inc., Other Affiliate Fresenius Kabi AG, Other Affiliate Fresenius SE & Co. KGaA for Fresenius Kabi USA, LLC filed by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Sep 6, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Martha C. Kidd for Cephalon, Inc., and for Teva Pharmaceuticals International GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Sep 6, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Shaun P. Mahaffy for Cephalon, Inc., and for Teva Pharmaceuticals International GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Sep 6, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney David I. Berl for Cephalon, Inc., and for Teva Pharmaceuticals International GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(lmm) |
| Sep 6, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Adam D. Harber for Cephalon, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(lmm) |
| Sep 1, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (10 in 1:17-cv-01164-GMS, 9 in 1:17-cv-01201-GMS) MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Adam D. Harber, Martha C. Kidd and Shaun P. Mahaffy filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. Ordered by Judge Gregory M. Sleet on 9/1/2017. Associated Cases: 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(mdb) |
| Aug 30, 2017 | 9 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Adam D. Harber, Martha C. Kidd and Shaun P. Mahaffy - filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Aug 30, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb) |
| Aug 29, 2017 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Teva Pharmaceuticals International GmbH, Cephalon, Inc., Eagle Pharmaceuticals, Inc.. Fresenius Kabi USA, LLC served on 8/25/2017, answer due 9/15/2017. (Hoeschen, Nathan) |
| Aug 25, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Fresenius Kabi USA, LLC on 8/25/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (fms) |
| Aug 24, 2017 | 1 | Exhibit A (29) |
| Aug 24, 2017 | 7 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Janus Henderson Group PLC for Eagle Pharmaceuticals, Inc. filed by Eagle Pharmaceuticals, Inc. (fms) |
| Aug 24, 2017 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd., Other Affiliate Teva Ltd. for Cephalon, Inc. filed by Cephalon, Inc. (fms) |
| Aug 24, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd., Other Affiliate Teva Ltd. for Teva Pharmaceuticals International GmbH filed by Teva Pharmaceuticals International GmbH. (fms) |
| Aug 24, 2017 | 4 | Patent/Trademark Report to Commissioner (3) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): See report for patent numbers. (fms) |
| Aug 24, 2017 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/14/2017. Date of Expiration of Patent: See form.Thirty Month Stay Deadline: 1/14/2020. (fms) |
| Aug 24, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (fms) |
| Aug 24, 2017 | 1 | Civil Cover Sheet (1) |
| Aug 24, 2017 | 1 | Exhibit M (8) |
| Aug 24, 2017 | 1 | Exhibit L (7) |
| Aug 24, 2017 | 1 | Exhibit K (13) |
| Aug 24, 2017 | 1 | Exhibit J (13) |
| Aug 24, 2017 | 1 | Exhibit I (13) |
| Aug 24, 2017 | 1 | Exhibit H (18) |
| Aug 24, 2017 | 1 | Exhibit G (12) |
| Aug 24, 2017 | 1 | Exhibit F (13) |
| Aug 24, 2017 | 1 | Exhibit E (10) |
| Aug 24, 2017 | 1 | Exhibit D (10) |
| Aug 24, 2017 | 1 | Exhibit C (9) |
| Aug 24, 2017 | 1 | Exhibit B (9) |
| Aug 24, 2017 | 1 | Complaint* (1) |
